Lilly partners with UnitedHealth Group for pragmatic study of bamlanivimab in high-risk COVID-19 patients

Eli Lilly and Company (Lilly) has formed a strategic collaboration with UnitedHealth Group to conduct a pragmatic clinical study on bamlanivimab (LY-CoV555), a monoclonal antibody ... Read More